Purchases and Sales Made in Q3 2022 in Essa Pharma Inc. (EPIX)
This table provides information about the institutional ownership of Essa Pharma Inc. (EPIX) during Q3 2022. The information is specifically focused on institutions that hold shares of ESSA Pharma Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2022
Q3 2022
|
Bvf Inc
San Francisco, CA |
BUY
|
- |
5.05M+ 136.54% |
$8.84M - $17.4M
|
8.75M
$14.3M
|
|
Nov 14, 2022
Q3 2022
|
Bellevue Group Ag
Kuesnacht, V8 |
BUY
|
- |
889K+ 17.74% |
$1.56M - $3.06M
|
5.9M
$9.67M
|
|
Nov 14, 2022
Q3 2022
|
Orbimed Advisors LLC
San Diego, CA |
BUY
|
- |
641KNew |
$1.12M - $2.2M
|
641K
$1.05M
|
|
Nov 14, 2022
Q3 2022
|
Pfm Health Sciences, LP
San Francisco, CA |
BUY
|
- |
517K+ 53.71% |
$904K - $1.78M
|
1.48M
$2.42M
|
|
Nov 14, 2022
Q3 2022
|
Woodline Partners LP
San Francisco, CA |
BUY
|
- |
382KNew |
$669K - $1.32M
|
382K
$627K
|
|
Nov 14, 2022
Q3 2022
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
296K+ 575.84% |
$519K - $1.02M
|
348K
$570K
|
|
Nov 14, 2022
Q3 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
BUY
|
- |
291K+ 570.06% |
$510K - $1M
|
342K
$562K
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
160K+ 626.21% |
$281K - $551K
|
186K
$305K
|
|
Nov 14, 2022
Q3 2022
|
D. E. Shaw & Co., Inc.
New York, NY |
BUY
|
- |
159K+ 46.74% |
$279K - $548K
|
500K
$820K
|
|
Nov 14, 2022
Q3 2022
|
Walleye Capital LLC
Plymouth, MN |
BUY
|
- |
133K+ 127.17% |
$232K - $457K
|
237K
$389K
|
|
Nov 14, 2022
Q3 2022
|
Marshall Wace, LLP
London, X0 |
BUY
|
- |
93.7K+ 438.13% |
$164K - $322K
|
115K
$189K
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
80K+ 24.49% |
$140K - $275K
|
407K
$667K
|
|
Nov 14, 2022
Q3 2022
|
Acadian Asset Management LLC
Boston, MA |
BUY
|
- |
72KNew |
$126K - $248K
|
72K
$118K
|
|
Nov 14, 2022
Q3 2022
|
Thrivent Financial For Lutherans
Minneapolis, MN |
BUY
|
- |
31.3KNew |
$54.8K - $108K
|
31.3K
$51.4K
|
|
Nov 14, 2022
Q3 2022
|
Cubist Systematic Strategies, LLC
Stamford, CT |
BUY
|
- |
25.7K+ 86.01% |
$45K - $88.5K
|
55.6K
$91.2K
|
|
Nov 14, 2022
Q3 2022
|
Xtx Topco LTD
London, X0 |
BUY
|
- |
23.3KNew |
$40.8K - $80.3K
|
23.3K
$38.3K
|
|
Nov 14, 2022
Q3 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
19.9KNew |
$34.8K - $68.4K
|
19.9K
$32.6K
|
|
May 14, 2024
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
12.8K+ 108.97% |
$22.4K - $44K
|
24.5K
$40.2K
|
|
Nov 10, 2022
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
12.8K+ 108.97% |
$22.4K - $44K
|
24.5K
$40.2K
|
|
Nov 14, 2022
Q3 2022
|
Hunting Hill Global Capital, LLC
New York, NY |
BUY
|
- |
10KNew |
$17.5K - $34.4K
|
10K
$16.4K
|
|
Nov 14, 2022
Q3 2022
|
Aquatic Capital Management LLC
Chicago, IL |
BUY
|
- |
3.3KNew |
$5.78K - $11.4K
|
3.3K
$5.41K
|
|
Nov 07, 2022
Q3 2022
|
Quantbot Technologies LP
New York, NY |
BUY
|
- |
2.15KNew |
$3.76K - $7.4K
|
2.15K
$3.53K
|
|
Nov 04, 2022
Q3 2022
|
Simplex Trading, LLC
|
BUY
|
- |
350New |
$613 - $1.2K
|
350
$574
|
|
Nov 14, 2022
Q3 2022
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
199+ 1.71% |
$348 - $685
|
11.9K
$19.5K
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 14, 2022
Q3 2022
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-1.63K- 22.04% |
$2.85K - $5.61K
|
5.77K
$9.45K
|
|
Nov 14, 2022
Q3 2022
|
Alps Advisors Inc
Denver, CO |
SELL
|
- |
-2.09K- 7.99% |
$3.65K - $7.18K
|
24.1K
$39.4K
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-5.21K- 23.71% |
$9.11K - $17.9K
|
16.8K
$27.5K
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-5.86K- 19.08% |
$10.3K - $20.2K
|
24.9K
$40.8K
|
|
Nov 14, 2022
Q3 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-8.66K- 99.91% |
$15.1K - $29.8K
|
8
$13.1
|
|
Nov 10, 2022
Q3 2022
|
Cibc World Market Inc.
Toronto, A6 |
SELL
|
- |
-17.3K- 18.34% |
$30.3K - $59.7K
|
77.2K
$127K
|
|
Nov 10, 2022
Q3 2022
|
Alp Invest Partners B.V.
Amsterdam, P7 |
SELL
|
- |
-66.5K- 62.47% |
$116K - $229K
|
39.9K
$65.5K
|
|
Nov 14, 2022
Q3 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-74.6K- 62.47% |
$131K - $257K
|
44.8K
$73.5K
|
|
Nov 10, 2022
Q3 2022
|
Candriam S.C.A.
|
SELL
|
- |
-150K- 26.41% |
$262K - $515K
|
418K
$685K
|
|
Nov 14, 2022
Q3 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-206K- 73.66% |
$361K - $709K
|
73.7K
$121K
|
|
Nov 14, 2022
Q3 2022
|
Bio Impact Capital LLC
Cambridge, MA |
SELL
|
- |
-255K- 38.61% |
$447K - $878K
|
406K
$665K
|
|
Nov 14, 2022
Q3 2022
|
Rtw Investments, LP
New York, NY |
SELL
|
- |
-1.33M- 50.28% |
$2.32M - $4.56M
|
1.31M
$2.15M
|
|
Nov 14, 2022
Q3 2022
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-1.53M- 36.66% |
$2.67M - $5.26M
|
2.64M
$4.33M
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.56M- 42.61% |
$2.74M - $5.38M
|
2.11M
$3.45M
|
|
Nov 14, 2022
Q3 2022
|
Eventide Asset Management, LLC
Boston, MA |
SELL
|
- |
-1.8M- 53.61% |
$3.16M - $6.21M
|
1.56M
$2.56M
|